Certificate

Kudelski IoT and Microchip Technology Solve Challenges & Pitfalls of IoT Provisioning With Joint Security Solution

Retrieved on: 
星期三, 四月 10, 2024
ICS, Certificate, Partnership, Keystream, Microchip Technology, Kudelski Group, Ecosystem, PKI, Corporation, Customer service

This strategic partnership marks a significant advancement in IoT device security, enabling dynamic, cloud-based provisioning and lifecycle management directly in the field.

Key Points: 
  • This strategic partnership marks a significant advancement in IoT device security, enabling dynamic, cloud-based provisioning and lifecycle management directly in the field.
  • We are excited to set a new benchmark in IoT security together with Kudelski IoT."
  • This collaboration between Kudelski IoT and Microchip Technology demonstrates a shared commitment to enhancing IoT security.
  • By providing a scalable, secure, and user-friendly platform for device provisioning and management, Kudelski IoT and Microchip Technology are setting a new standard in IoT security.

Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute

Retrieved on: 
星期二, 四月 9, 2024
Psilocybin, First Nations, Wharerātā, Certificate, Patient, Ethics, FRA, COA, Synthetic, Health Canada, Trial of the century, GMP, Clinical trial, Ground substance, Safety, MDMA, Medsafe, Medicine, Pharmaceutical industry

VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, is proud to announce the signing of an international natural psilocybin supply agreement with New Zealand-Based Mātai Medical Research Institute (Mātai), on behalf of the Tū Wairua Project.

Key Points: 
  • VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, is proud to announce the signing of an international natural psilocybin supply agreement with New Zealand-Based Mātai Medical Research Institute (Mātai), on behalf of the Tū Wairua Project.
  • This agreement marks Optimi's first supply deal to New Zealand, a significant milestone for the company's global expansion efforts.
  • Under the terms of the agreement, Optimi will provide Mātai with a quantity of its validated GMP Full Spectrum Natural Psilocybin extract.
  • Further, the agreement includes tracked stability of the extract, ensuring the highest standards of GMP quality and compliance.

Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract

Retrieved on: 
星期二, 四月 2, 2024
Psilocybin, Psilocybe, Organization, Documentation, Learning, Certificate, Patient, Research, Good manufacturing practice, FRA, COA, International Council, Health Canada, GMP, Data collection, Quality, Harmonization, Ground substance, GACP, Water, Safety, ICH, MDMA, Good

Additionally, the Company has successfully completed the in-house encapsulation of psilocybin drug candidates in 5mg and 10mg dosage formats.

Key Points: 
  • Additionally, the Company has successfully completed the in-house encapsulation of psilocybin drug candidates in 5mg and 10mg dosage formats.
  • The third-party COA confirms critical information regarding potency, water content, microbial content, and heavy metal content, ensuring that the Natural Psilocybin Extract meets the predetermined specifications.
  • The completion of both extract validation and finished product testing aligns with Optimi's goal of advancing the drug candidate, marking significant progress toward its eventual release for human consumption.
  • “Obtaining successful results on the validation batches of psilocybin extract speaks to Optimi’s dedication to developing a repeatable, quality focused manufacturing process.

Microchip Technology Introduces ECC608 TrustMANAGER with Kudelski IoT keySTREAM

Retrieved on: 
星期二, 四月 2, 2024
Software as a service, Certificate, Partnership, Internet of things, Keystream, Software, Microchip Technology, MCHP, Ecosystem, Certificate authority, PKI, Integrated circuit, Silicon, Cryptocurrency

To increase security on IoT products and facilitate easier setup and management, Microchip Technology (Nasdaq: MCHP) has added the ECC608 TrustMANAGER with Kudelski IoT keySTREAM, Software as a Service (SaaS) to its Trust Platform portfolio of devices, services and tools.

Key Points: 
  • To increase security on IoT products and facilitate easier setup and management, Microchip Technology (Nasdaq: MCHP) has added the ECC608 TrustMANAGER with Kudelski IoT keySTREAM, Software as a Service (SaaS) to its Trust Platform portfolio of devices, services and tools.
  • The ECC608 TrustMANAGER relies on a secure authentication IC that is designed to store and protect cryptographic keys and certificates, which are then managed by the keySTREAM SaaS.
  • “The ECC608 TrustMANAGER with keySTREAM marks a pivotal moment in our quest to secure the IoT landscape and make provisioning easier.
  • To get started, download the Trust Platform Design Suite and test the keySTREAM use case under the ECC608 TrustMANAGER.

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023

Retrieved on: 
星期五, 三月 29, 2024
Sales management, Health, Plan, Growth, Certificate, Purchasing, Patient, Sale, Transport, John L. Hall, Shenzhen Stock Exchange, Special, Cryptocurrency

HOUSTON, TEXAS, March 29, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced its financial results for the year ended December 31, 2023. The Company also provided a corporate update to stockholders.

Key Points: 
  • Financial highlights for the year ended December 31, 2023 include the following:
    Total revenue was $12,248,550 for the year ended December 31, 2023, as compared to $11,049,772 for the year ended December 31, 2022, an increase of $1,198,778, or 10.8%.
  • The Viactiv® product line accounted for approximately 97.2% and 96.3% of total revenue for the years ended December 31, 2023 and 2022, respectively.
  • Total operating expenses for the year ended December 31, 2023 were $9,730,834, as compared to $21,940,985 for the year ended December 31, 2022.
  • Loss from operations for the year ended December 31, 2023 was $(4,336,317), as compared to $(17,420,598) for the year ended December 31, 2022.

MIND Technology Announces Deferral of Preferred Stock Dividend

Retrieved on: 
星期五, 四月 5, 2024
Rights, MIND, The Company, Certificate, Holding company

THE WOODLANDS, Texas, April 5, 2024 /PRNewswire/ -- MIND Technology, Inc. ("MIND" or the "Company") (Nasdaq: MIND) announced today that the Company's Board of Directors (the "Board") has elected not to declare a quarterly cash dividend on its 9.00% Series A Cumulative Preferred Stock ("Series A Preferred Stock") for the first quarter of its fiscal year ending January 31, 2025.

Key Points: 
  • THE WOODLANDS, Texas, April 5, 2024 /PRNewswire/ -- MIND Technology, Inc. ("MIND" or the "Company") (Nasdaq: MIND) announced today that the Company's Board of Directors (the "Board") has elected not to declare a quarterly cash dividend on its 9.00% Series A Cumulative Preferred Stock ("Series A Preferred Stock") for the first quarter of its fiscal year ending January 31, 2025.
  • The Company may defer dividend payments on the Series A Preferred Stock, but the dividend is a cumulative dividend that accrues for payment in the future.
  • The deferral of the dividend on the Series A Preferred Stock for the first quarter of the fiscal year ending January 31, 2025 is the seventh quarterly dividend to be deferred.
  • Accordingly, holders of Series A Preferred Stock have the right to appoint two directors to the Board pursuant to the specific provisions of the Certificate of Designations, Preferences and Rights of MIND Technology, Inc. 9.00% Series A Cumulative Preferred Stock, as amended.

Montauk Renewables Announces Full Year 2023 Results

Retrieved on: 
星期四, 三月 14, 2024
Kilowatt-hour, Natural gas, Squat toilet, Certificate, D3, Webcast, Sale, Public expenditure, Table, Apex, RIN, Adjustment, GAAP, Security, British thermal unit, Electricity, Primary energy, RNG, Digestion, Bookkeeping

PITTSBURGH, March 14, 2024 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery, and conversion of biogas into renewable natural gas (“RNG”), today announced financial results for the year ended December 31, 2023.

Key Points: 
  • PITTSBURGH, March 14, 2024 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery, and conversion of biogas into renewable natural gas (“RNG”), today announced financial results for the year ended December 31, 2023.
  • However, lower prices of both the average realized price of RINs sold and natural gas resulted in lower revenues in 2023.
  • These 2023 price driven reductions to revenues of approximately $30.7 million were offset through our tiered royalty structure reducing royalty expense in 2023 by approximately $9.3 million, which led to our $20.9 million reduction in 2023 operating income.
  • Our average pricing realized on RIN sales during 2023 of $2.71 exceeded the average D3 RIN index price of $2.63 during 2023.

Moses Singer Welcomes Back Tech & Data Specialist Liberty McAteer

Retrieved on: 
星期一, 四月 1, 2024
Data Management, Banking, Technology, Professional Services, Patent Law, Data Analytics, Software, Artificial Intelligence, Legal, Hardware, Finance, E-commerce, Physics, EV, Software as a service, Liberty, Growth, Certificate, Philosophy, Help desk, McAteer, Data, Social media, Warner Bros. Discovery EMEA, AI, Brooklyn Law School, Silicon, Fintech, Intellectual property, Machine learning, Privacy, Wesleyan University

Moses & Singer LLP is pleased to announce the return of Liberty McAteer as a partner in its Intellectual Property and AI & Data Law groups as the firm continues its strategic investment in growing their Data and AI practice.

Key Points: 
  • Moses & Singer LLP is pleased to announce the return of Liberty McAteer as a partner in its Intellectual Property and AI & Data Law groups as the firm continues its strategic investment in growing their Data and AI practice.
  • Liberty rejoins the firm after serving as Deputy Counsel at FreeWire Technologies, Inc., a Silicon Valley based battery-integrated EV charging station manufacturer.
  • “Liberty’s deep software and programming background sets him apart from other transactional lawyers,” said Dean Swagert , Moses Singer Managing Partner and co-chair of the Corporate Practice Group.
  • Liberty is also an active coder and charter member of TechGC, a peer community for professional development.

Latest Iteration of GMO GlobalSign's PKIaaS Connector for ServiceNow Features Significantly Expanded Certificate Lifecycle Management Capabilities

Retrieved on: 
星期二, 三月 19, 2024
Online Privacy, Technology, Security, Marketing, Advertising, Communications, Software, Internet, Digital Marketing, IOT (Internet of Things), Automation, Organization, Certificate, ServiceNow, Internet of things, GlobalSign, GMO, Policy, Digital, Reduction

GMO GlobalSign, Inc. a global Certificate Authority (CA) and leading provider of identity security, digital signing and IoT solutions, today announced the availability of the latest iteration of its PKIaaS Connector for ServiceNow .

Key Points: 
  • GMO GlobalSign, Inc. a global Certificate Authority (CA) and leading provider of identity security, digital signing and IoT solutions, today announced the availability of the latest iteration of its PKIaaS Connector for ServiceNow .
  • Through ServiceNow’s connection to GMO GlobalSign’s certificate management platform, Atlas , enterprises can easily manage their digital certificate requests within their existing ServiceNow instance.
  • With the upgrades in GMO GlobalSign’s PKIaaS Connector, ServiceNow users have expanded certificate lifecycle management capabilities for manual and automated certificate renewal, retrieve and update certificates, filter by expiration, send certificates in email and support expiry notifications via email.
  • These new capabilities of the PKIaaS Connector are ideal for ServiceNow customers who require a better way to manage certificate automation, especially with rapidly decreasing certificate lifecycles.

MIND Technology Proposes Amendment to Terms of Preferred Stock

Retrieved on: 
星期一, 三月 25, 2024
The Company, Virtual, Growth, Certificate, Rights, MIND, Security (finance)

THE WOODLANDS, Texas, March 25, 2024 /PRNewswire/ -- MIND Technology, Inc. ("MIND" or the "Company") (Nasdaq: MIND; MINDP) announced today that it has begun soliciting proxies from holders of its 9% Series A Cumulative Preferred Stock (the "preferred stock") to approve an amendment to the Certificate of Designations, Preferences and Rights of the preferred stock.

Key Points: 
  • THE WOODLANDS, Texas, March 25, 2024 /PRNewswire/ -- MIND Technology, Inc. ("MIND" or the "Company") (Nasdaq: MIND; MINDP) announced today that it has begun soliciting proxies from holders of its 9% Series A Cumulative Preferred Stock (the "preferred stock") to approve an amendment to the Certificate of Designations, Preferences and Rights of the preferred stock.
  • Under the proposed amendment, each share of preferred stock would be converted into 2.7 shares of common stock, $0.01 par value per share (the "common stock"), at the sole discretion of the Company's Board of Directors at any time prior to July 31, 2024 (the "Preferred Stock Proposal").
  • The affirmative vote of two-thirds (66 2/3%) of the outstanding shares of preferred stock is required for approval of the Preferred Stock Proposal.
  • "Based on the relative market values of the preferred stock and common stock as of March 11, 2024, a conversion would provide preferred stockholders approximately a 110% premium to the market value of the Preferred stock, with the potential to participate in the Company's further growth.